Alerts will be sent to your verified email
Verify Email
3BBLACKBIO
|
3B Blackbio Dx
|
Nureca Ltd.
|
Genpharmasec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
33.92 % | 33.5 % | 3.69 % |
|
5yr average Equity Multiplier
|
1.4 | 1.74 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.63 | 1.65 | 0.81 |
|
5yr Avg Net Profit Margin
|
36.24 % | 9.68 % | 15.44 % |
|
Price to Book
|
2.87 | 1.41 | 8.37 |
|
P/E
|
21.88 | 0.0 | 118.41 |
|
5yr Avg Cash Conversion Cycle
|
163.91 Days | 140.67 Days | 167.68 Days |
|
Inventory Days
|
41.19 Days | 73.5 Days | 85.85 Days |
|
Days Receivable
|
188.65 Days | 11.25 Days | 86.95 Days |
|
Days Payable
|
71.11 Days | 36.21 Days | 67.59 Days |
|
5yr Average Interest Coverage Ratio
|
260.03 | 29.97 | 1.21 |
|
5yr Avg ROCE
|
40.11 % | 42.4 % | 2.82 % |
|
5yr Avg Operating Profit Margin
|
50.56 % | 14.47 % | 18.2 % |
|
5 yr average Debt to Equity
|
0.09 | 0.14 | 0.04 |
|
5yr CAGR Net Profit
|
37.7 % | n/a | 37.25 % |
|
5yr Average Return on Assets
|
23.85 % | 16.71 % | 2.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.29 % | 63.24 % | 29.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.94 % | -6.76 % | -29.98 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -1.63 % | 0.0 |
|
3B Blackbio Dx
|
Nureca Ltd.
|
Genpharmasec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
